IP Library Granted Patent US 6,871,650
Granted Patent B1
US 6,871,650 · App. 09/591,874 · Granted Mar 29, 2005

Contraceptive transcervical fallopian tube occlusion devices and their delivery

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 6,871,650
App. No.
09/591,874
Granted
Mar 29, 2005
Kind
B1
Abstract

The invention provides intrafallopian devices and non-surgical methods for their placement to prevent conception. The efficacy of the device is enhanced by forming the structure at least in part from copper or a copper alloy. The device is anchored within the fallopian tube by imposing a secondary shape on a resilient structure, the secondary shape having a larger cross-section than the fallopian tube. The resilient structure is restrained in a straight configuration and transcervically inserted within the fallopian tube, where it is released. The resilient structure is then restrained by the walls of the fallopian tube, imposing anchoring forces as it tries to resume the secondary shape.

Claims (8)

1. A system for providing permanent sterilization, the system comprising:

a flexible structure;

a plurality of fibers affixed to the structure, the fibers adapted to promote tissue ingrowth around the structure sufficient to provide permanent sterilization when disposed in a fallopian tube;

an elongate body having a proximal end and a distal end, the elongate body releasably supporting the flexible structure within the distal end; and

a hysteroscope through which the distal end of the elongate body is extendible while the hysteroscope is inserted transcervically, the hysteroscope providing an image from within the uterus to direct the elongate body laterally toward an ostium of the fallopian tube.

2. The system of claim 1 , wherein the fibers induce tissue ingrowth when the flexible structure and fibers are advanced into the ostium and detached from the elongate body therein.

3. The system of claim 2 , wherein the fibers comprise a polyester material.

4. The system of claim 2 , wherein the structure has a first cross-section when supported by the elongate body and can define a second cross-section when deployed, the second cross-section being larger than the first cross-section.

Assignments (1)
CHANGE OF NAME Recorded Jan 16, 2014
From: CONCEPTUS, INC.
To: BAYER ESSURE INC.
Reel/Frame 032075/0466 →